Form 4: Rocket Pharmaceuticals Director Gotham Makker Sells 274,000 Shares

Director Gotham Makker sold 274,000 shares of Rocket Pharmaceuticals (RCKT) at a price of $28.4341 on March 21, 2024.

Summary

• On March 21, 2024, Gotham Makker, a director of Rocket Pharmaceuticals, sold 274,000 shares of common stock.
• The sale price was $28.4341 per share.
• Following the transaction, Makker directly owns 365,912 shares indirectly through Simran Investment Group.
• Makker disclaims personal beneficial ownership of the reported securities held by Simran Investment Group, except to the extent of his pecuniary interest therein.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a transaction by a company insider. The sentiment is neutral as it simply reports a sale of shares.

Industry Context

Sales of shares by company directors are a normal part of corporate activity. It is important to consider the context of the sale, such as the director's overall holdings and any stated reasons for the sale.

Stakeholder Impact

• The sale of shares by a director could potentially influence investor sentiment, although the impact is likely to be minimal given the size of the transaction relative to the company's overall market capitalization.

Key Dates